Gefitinib and PEG-interferon alfa-2a in treating patients with unresectable or metastatic skin cancer.

Journal of Drugs in DermatologyVol. 6 Nbr. 4, April 2007

Linked as:

Summary


CLINICAL TRIAL REVIEW - Brief article

See the full content of this document

Extract


Gefitinib and PEG-interferon alfa-2a in treating patients with unresectable or metastatic skin cancer.

Sponsors and Collaborators: Uni...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company